Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
Urologic Oncology
|
June 22, 2025
Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study group
Alissa Groenendijk, Harm van Tinteren, Ronald R de Krijger, et al.
JCO Clinical Cancer Informatics
|
June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies
Prakriti Roy, Ingrid Schut, Norbert Graf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2022
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols
Alissa Groenendijk, Harm van Tinteren, Yilin Jiang, et al.
Tumori
|
July 1, 2017
Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over Italy
Matteo Silva, Marco Chisari, Stefano Signoroni, et al.
Journal of Neuro-Oncology
|
June 23, 2020
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients
Maura Massimino, Marie Pierre Sunyach, Francesco Barretta, et al.
Nature Reviews. Urology
|
January 29, 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J O'Sullivan, Amy L Walz, et al.
Plos One
|
May 26, 2026
Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols
Paola Quarello, Rana Dandis, Tanzina Chowdhury, et al.
Neuro-Oncology
|
September 27, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype
Maura Massimino, Francesco Barretta, Chiara Dossena, et al.
JCO Global Oncology
|
June 13, 2024
Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala
Daniel C Moreira, Claudia Garrido, Roy Rosado, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
Urologic Oncology
|
June 22, 2025
Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study group
Alissa Groenendijk, Harm van Tinteren, Ronald R de Krijger, et al.
JCO Clinical Cancer Informatics
|
June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies
Prakriti Roy, Ingrid Schut, Norbert Graf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2022
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols
Alissa Groenendijk, Harm van Tinteren, Yilin Jiang, et al.
Tumori
|
July 1, 2017
Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over Italy
Matteo Silva, Marco Chisari, Stefano Signoroni, et al.
Journal of Neuro-Oncology
|
June 23, 2020
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients
Maura Massimino, Marie Pierre Sunyach, Francesco Barretta, et al.
Nature Reviews. Urology
|
January 29, 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J O'Sullivan, Amy L Walz, et al.
Plos One
|
May 26, 2026
Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols
Paola Quarello, Rana Dandis, Tanzina Chowdhury, et al.
Neuro-Oncology
|
September 27, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype
Maura Massimino, Francesco Barretta, Chiara Dossena, et al.
JCO Global Oncology
|
June 13, 2024
Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala
Daniel C Moreira, Claudia Garrido, Roy Rosado, et al.
Page
of 19